Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: tonyt who wrote (20343)	5/10/1998 8:50:00 PM
From: Andreas Helke	Respond to of 32384

I still expect that Lignad will do sufficiently better compared to the S&P500 to make up for its lacking performance in the last two years. I consider my investing to be mostly as ownership in promising business opportunities. As such my investment in Ligand was a success. Ligand has made steady progress since I began buying shares. As long as the business development goes according to my expectations I will keep my investment even if the share prices don't go up immediately. I will neither start trading the shares nor dump them to chase the next hot idea. I have found in the last few years that when you chase stocks you have a very high probability to pay too much and if you then give up in disgust you have a big chance to sell at or near the bottom. I sold Quantum and the last of my Applied Materials shares for a big loss at their exact 1996 bottoms. For the Quantum money I bought Seagate which was liked better by the analysts but unfortunately did much worse than Quantum. And then I sold Seagate much too early. For my AMAT money I bought network and DSL equipment stocks which looked cheap at the time but turned out later to have been pretty expensive. Now much of that money has found its way into Ligand a stock that can still be bought at the same prices that it had two years ago. I rarely got my shares at optimal prices and missed several trading opportunities and other potential investment that have turned out to have had better price appreciation. But if we knew ahead of the time what works in the next few months we would all be rich. Trading is for me only an emergency measure that I take if my portfolio is down and I think I have to accept the higher risk of a trading strategy to make any money at all. Ligand has a very good chance to deliver the kind of superior revenue growth in the next few years that almost inevitably will be followed by decent stock price appreciation. Andreas